Sunshine Biopharma Inc. (SBFMW) Financial Forecast
United States · Industrial & Consumer Products · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
-25.68%
2025 (actual)
ROA
-19.71%
2025 (actual)
Gross Margin
33.76%
2025 (actual)
Net Margin
-16.46%
2025 (actual)
Total Assets
$30,079.17K
2025 (actual)
Net Income
-$5,975.35K
2025 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+344.2 pt
Company
Sector average
ROA
-11.6 pt
Company
Gross Margin
-1.2 pt
Company
Sector average
Net Margin
+2.9 pt
Company
Total Assets
-24.5%
Company
Sector average (own scale)
Net Income
-16.9%
Company
Detailed data
USD|Thousands
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Sunshine Biopharma Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.